Kroger Company (The)
66.04-1.65 (-2.44%)
Oct 29, 4:00:02 PM EDT · NYSE · KR · USD
Key Stats
Market Cap
43.76BP/E (TTM)
16.76Basic EPS (TTM)
3.94Dividend Yield
0.02%Recent Filings
8-K
Kroger boosts Q2 results, guidance
Kroger reported Q2 2025 sales flat at $33.9 billion, but identical sales without fuel surged 3.4%, fueled by 16% eCommerce growth and strong pharmacy volumes. Adjusted EPS climbed to $1.04 from $0.93, with gross margin up to 22.5% thanks to lower shrink and supply costs, despite the Kroger Specialty Pharmacy sale. The company raised full-year guidance to 2.7%-3.4% identical sales growth and $4.70-$4.80 adjusted EPS. Momentum builds, yet merger litigation lingers.
8-K
Kroger's annual meeting outcomes
The Kroger Co. held its 2025 Annual Meeting on June 26, electing all ten nominated directors with strong support, approving executive compensation and PwC's audit ratification, while rejecting three shareholder proposals on environmental and privacy reports. Technical glitches cut the webcast's final Q&A, but the company disclosed its response: Kroger anticipates minimal tariff impacts versus peers, actively sourcing alternatives with suppliers, and views price hikes as a last resort amid customer value needs. Shareholders signal confidence in leadership continuity.
10-Q
Q1 FY2026 results
Kroger's Q1 sales dipped 0.3% y/y to $45.1B, pressured by a 12.5% drop in fuel sales, yet identical sales excluding fuel rose 3.2% on strong pharmacy, eCommerce (up 15%), and Fresh momentum. Operating profit edged up 2.2% y/y to $1.3B, with gross margin expanding to 23.0% from 22.0% amid lower shrink and supply chain costs, while OG&A climbed to 17.6% on healthcare and pension contributions. Diluted EPS held steady at $1.29, reconciling neatly with 664M shares and $866M net earnings, down 8.6% y/y but buoyed by share repurchases. Cash swelled to $4.7B, with operating cash flow at $2.1B funding $1.0B capex and $0.4B returns; total debt stayed flat at $17.9B with full revolver availability. Store closures hit $100M in charges for 60 locations over 18 months, promising modest savings reinvested in customer experience. Opioid settlements advanced with $138M paid, yet litigation lingers from non-participants. Kroger's model churns steady growth. Fuel volatility shadows margins.
8-K
Kroger boosts Q1 sales guidance
Kroger reported solid Q1 2025 results, with identical sales without fuel up 3.2% and eCommerce sales surging 15%, driven by strong pharmacy, fresh, and digital growth. Total sales dipped slightly to $45.1 billion amid the Kroger Specialty Pharmacy sale, yet adjusted FIFO operating profit climbed to $1,518 million from $1,499 million last year, thanks to lower shrink and supply chain costs. The company raised full-year identical sales guidance to 2.25%-3.25% while reaffirming profit targets. Store closures loom.
10-K
FY2024 results
Kroger's FY2024 sales dipped 0.1% to $147.1B, but excluding fuel and the prior year's extra week, they rose 0.9% amid 1.5% identical sales growth without fuel, fueled by loyal households and digital sales surging 11%. Q4 momentum shone with 18% delivery growth, lifting adjusted FIFO operating profit to $4.7B despite a 2.6% annual dip, while net earnings per diluted share hit $3.67, up 24% on lower opioid charges. Strong pharmacy and Our Brands drove margins up 32 basis points, yet fuel sales fell 8.4% y/y. Liquidity bolstered by $4.0B cash, $2.75B credit availability, and $5.1B returned via buybacks and dividends; no 2025 guidance disclosed. Intense competition from discounters and e-commerce could stall quarterly gains.
IPO
Website
Employees
Sector
Industry
ACI
Albertsons Companies, Inc.
18.27-0.20
CRERF
Carrefour S.A.
15.49+0.00
DDL
Dingdong (Cayman) Limited
1.87-0.04
DNUT
Krispy Kreme, Inc.
3.79-0.25
GO
Grocery Outlet Holding Corp.
14.34-0.28
KLG
WK Kellogg Co
23.00+0.00
NGVC
Natural Grocers by Vitamin Cott
38.61-0.89
SFM
Sprouts Farmers Market, Inc.
104.55-2.25
VLGEA
Village Super Market, Inc.
31.45-0.67
WMK
Weis Markets, Inc.
64.38-1.54